1/11
04:41 pm
lab
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team [Yahoo! Finance]
Medium
Report
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team [Yahoo! Finance]
1/8
07:00 am
lab
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
High
Report
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
12/28
09:03 am
lab
Standard BioTools: Outlook Still Murky [Seeking Alpha]
Medium
Report
Standard BioTools: Outlook Still Murky [Seeking Alpha]
12/28
08:37 am
lab
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses [Yahoo! Finance]
Medium
Report
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses [Yahoo! Finance]
12/13
07:50 am
lab
Standard BioTools (NASDAQ:LAB) was upgraded by analysts at Zacks Research to a "hold" rating.
Medium
Report
Standard BioTools (NASDAQ:LAB) was upgraded by analysts at Zacks Research to a "hold" rating.
11/19
12:00 pm
lab
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry [Yahoo! Finance]
Low
Report
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry [Yahoo! Finance]
11/19
11:30 am
lab
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
Low
Report
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
11/5
02:21 pm
lab
Standard BioTools (NASDAQ:LAB) had its price target lowered by analysts at TD Cowen from $1.55 to $1.35. They now have a "hold" rating on the stock.
Low
Report
Standard BioTools (NASDAQ:LAB) had its price target lowered by analysts at TD Cowen from $1.55 to $1.35. They now have a "hold" rating on the stock.
11/4
04:05 pm
lab
Standard BioTools Reports Third Quarter 2025 Financial Results
Medium
Report
Standard BioTools Reports Third Quarter 2025 Financial Results
10/21
07:00 am
lab
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
Low
Report
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025